In 1998, Andrew Fire and Craig Mello reported that double-stranded RNA (dsRNA) had potent gene silencing effects in Caenorhabditis elegans , 38 a discovery they termed RNA interference (RNAi)
Health authority regulations in the US and Europe require pharmaceutical companies to conduct a pre-approval trial showing at least non-inferiority of cardiovascular (CV) safety compared with placebo treatment, for any new therapy to treat type 2 diabetes (T2D), prior to granting market approval
These diabetes-specific results mirror the pattern seen with CagriSema in REDEFINE 2, though direct comparison requires caution because the trial populations and designs differed
Absolute lymphocyte and platelet counts are lower in MIS-C compared with KD
In the brain, its actions may be mediated by NMDA receptors
The methylation of the APC gene promoter is a potential biomarker for the diagnosis of LC